EC/Australia/New Zealand soon in talks over extending scope of MRA:
This article was originally published in Clinica
Executive Summary
The European Commission is hoping to have a joint meeting with the Australian and New Zealand authorities under the Trans Tasmanian agreement in the first half of May to discuss extending the scope of the MRA between the markets. Discussions will focus on the practical details involved in adding new risk classes as well as IVDs.